SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-008798
Filing Date
2023-05-09
Accepted
2023-05-09 16:02:01
Documents
80
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q kala-20230331x10q.htm   iXBRL 10-Q 2125438
2 EX-3.2 kala-20230331xex3d2.htm EX-3.2 167002
3 EX-31.1 kala-20230331xex31d1.htm EX-31.1 15200
4 EX-31.2 kala-20230331xex31d2.htm EX-31.2 15174
5 EX-32.1 kala-20230331xex32d1.htm EX-32.1 6713
6 EX-32.2 kala-20230331xex32d2.htm EX-32.2 6839
  Complete submission text file 0001558370-23-008798.txt   8519680

Data Files

Seq Description Document Type Size
7 EX-101.SCH kala-20230331.xsd EX-101.SCH 65614
8 EX-101.CAL kala-20230331_cal.xml EX-101.CAL 58071
9 EX-101.DEF kala-20230331_def.xml EX-101.DEF 288389
10 EX-101.LAB kala-20230331_lab.xml EX-101.LAB 527922
11 EX-101.PRE kala-20230331_pre.xml EX-101.PRE 411233
74 EXTRACTED XBRL INSTANCE DOCUMENT kala-20230331x10q_htm.xml XML 1339786
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38150 | Film No.: 23901792
SIC: 2834 Pharmaceutical Preparations